Terapéutica de la insuficiencia cardíaca en adultos mayores

Abstract

Heart failure is considered a chronic disease, which can result from any structural or functional cardiac disorder that decreases the capacity of the ventricle in the expulsion of blood, it is considered to be the final phase of most heart diseases due to multifactorial causes. In advanced age, the incidence and prevalence increases by 80% in patients over 65 years of age. Despite multiple treatments, morbidity and mortality are still high. Not using the appropriate drugs, not prescribing adequate doses in conjunction with an inappropriate lifestyle have influenced the mortality of older adults. The main objective of this research was to analyze advances and improvements in treatment in elderly patients with chronic heart failure through a review of the literature with qualified sources that provide accurate information, reviewed scientific journals indexed (scielo, redalyc and scopus), academic google, pubmed among other high impact sources in the field of medicine. A selection of scientific articles of recent years was made with topics related to the treatment of HF in older adults. Based on the information collected, it was determined that the drugs most used in the treatment of CHF in older adults are: Captopril, Enalapril, Carvediol, Bisoprolol and Metaprolol in the group of ACEI and BB and other authors consider that for the treatment of CCI the appropriate drugs are: Valsartan and Sacubitril (ARA II) and, Acetylsalicylic acid (Aspirin) and warfarin (anticoagulants).